OAR 944-010-0060: Harm Reduction Services, Information and Education
Edition: Current OARD snapshotEffective: 2024-11-01Last verified: 2026-09-07
(1) Harm reduction services provided by an entity funded under ORS 430.389(2) must be low-barrier and must reduce the negative individual and public health outcomes of substance use and substance related harm. (2) Harm reduction services provided by a funded entity can include but are not limited to: (a) Access to naloxone; (b) Sterile syringes; (c) Safer use and wound care supplies; (d) Substance use-related infectious disease screening; (e) Sobering support; (f) Contingency management; (g) Drug checking supplies; and (h) Information and education about harm reduction services. (i) Referral for Hepatitis, HIV, STI, COVID-19, and Tuberculosis (TB) testing, vaccine, or other healthcare services.
Official history and status
Statutory/Other Authority: ORS 430.389, 430.390 & 430.391
Statutes/Other Implemented: ORS 430.383 & 430.392
History: DTRS 3-2024, adopt filed 10/22/2024, effective 11/01/2024 DTRS 1-2024, temporary adopt filed 05/30/2024, effective 06/01/2024 through 11/27/2024
This rule cites
- ORS 430.389(2) — resolved
Cited by
No inbound citations found.
Official source: https://secure.sos.state.or.us/oard/